Brazil manufactures its own generic version of Gilead's Viread

A state-owned lab in Brazil, with the help of privately-owned local companies, has begun manufacturing its own generic version of Gilead Sciences's antiretroviral Viread (tenofovir), says the health ministry. The news comes two years after the national intellectual property institute, INPI, rejected Gilead Sciences's patent application for Viread.